220 related articles for article (PubMed ID: 10089303)
1. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.
Liang J; Choi J; Clardy J
Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):736-44. PubMed ID: 10089303
[TBL] [Abstract][Full Text] [Related]
2. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
Choi J; Chen J; Schreiber SL; Clardy J
Science; 1996 Jul; 273(5272):239-42. PubMed ID: 8662507
[TBL] [Abstract][Full Text] [Related]
3. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression.
Vilella-Bach M; Nuzzi P; Fang Y; Chen J
J Biol Chem; 1999 Feb; 274(7):4266-72. PubMed ID: 9933627
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
[TBL] [Abstract][Full Text] [Related]
5. Structure of FKBP12.6 in complex with rapamycin.
Deivanayagam CC; Carson M; Thotakura A; Narayana SV; Chodavarapu RS
Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):266-71. PubMed ID: 10713512
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the FKBP.rapamycin.FRB ternary complex.
Banaszynski LA; Liu CW; Wandless TJ
J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
[TBL] [Abstract][Full Text] [Related]
7. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
Sapienza PJ; Mauldin RV; Lee AL
J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
[TBL] [Abstract][Full Text] [Related]
8. Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity.
Rejto PA; Verkhivker GM
Proteins; 1997 Jul; 28(3):313-24. PubMed ID: 9223178
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a plant FKBP12 that does not mediate action of FK506 and rapamycin.
Xu Q; Liang S; Kudla J; Luan S
Plant J; 1998 Aug; 15(4):511-9. PubMed ID: 9753776
[TBL] [Abstract][Full Text] [Related]
10. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu MI; Katz H; Berlin V
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12574-8. PubMed ID: 7809080
[TBL] [Abstract][Full Text] [Related]
11. The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.
Choi JH; Bertram PG; Drenan R; Carvalho J; Zhou HH; Zheng XF
EMBO Rep; 2002 Oct; 3(10):988-94. PubMed ID: 12231510
[TBL] [Abstract][Full Text] [Related]
12. A Binding Site Hotspot Map of the FKBP12-Rapamycin-FRB Ternary Complex by Photoaffinity Labeling and Mass Spectrometry-Based Proteomics.
Flaxman HA; Chang CF; Wu HY; Nakamoto CH; Woo CM
J Am Chem Soc; 2019 Jul; 141(30):11759-11764. PubMed ID: 31309829
[TBL] [Abstract][Full Text] [Related]
13. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility.
Sormani R; Yao L; Menand B; Ennar N; Lecampion C; Meyer C; Robaglia C
BMC Plant Biol; 2007 Jun; 7():26. PubMed ID: 17543119
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
Alarcon CM; Heitman J; Cardenas ME
Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
Veverka V; Crabbe T; Bird I; Lennie G; Muskett FW; Taylor RJ; Carr MD
Oncogene; 2008 Jan; 27(5):585-95. PubMed ID: 17684489
[TBL] [Abstract][Full Text] [Related]
18. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.
Chen J; Zheng XF; Brown EJ; Schreiber SL
Proc Natl Acad Sci U S A; 1995 May; 92(11):4947-51. PubMed ID: 7539137
[TBL] [Abstract][Full Text] [Related]
19. The role of glycerol-water mixtures in the stability of FKBP12-rapalog-FRB complexes.
Lopez JJD; Gaza JT; Nellas RB
J Mol Graph Model; 2023 Nov; 124():108556. PubMed ID: 37423019
[TBL] [Abstract][Full Text] [Related]
20. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
